| scholarly article | Q13442814 |
| P50 | author | Monika L Metzger | Q91391717 |
| John T Sandlund | Q114431525 | ||
| Deepa Bhojwani | Q42324985 | ||
| Wilburn E Reddick | Q55458911 | ||
| Jeffrey Rubnitz | Q57306302 | ||
| Mary V Relling | Q88331217 | ||
| P2093 | author name string | John C Panetta | |
| Ching-Hon Pui | |||
| William E Evans | |||
| Hiroto Inaba | |||
| Cheng Cheng | |||
| Kevin R Krull | |||
| Sima Jeha | |||
| Deqing Pei | |||
| Scott C Howard | |||
| Raul C Ribeiro | |||
| Raja B Khan | |||
| Jun J Yang | |||
| Noah D Sabin | |||
| P2860 | cites work | Inference of population structure using multilocus genotype data | Q24548114 |
| Autism genome-wide copy number variation reveals ubiquitin and neuronal genes | Q24629598 | ||
| Treating childhood acute lymphoblastic leukemia without cranial irradiation | Q24644599 | ||
| Astn2, a novel member of the astrotactin gene family, regulates the trafficking of ASTN1 during glial-guided neuronal migration | Q28115873 | ||
| Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate | Q28250460 | ||
| Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate | Q28318775 | ||
| Echovirus 30 induced neuronal cell death through TRIO-RhoA signaling activation | Q28483464 | ||
| Genome-wide association analysis identifies susceptibility loci for migraine without aura | Q29416996 | ||
| Population PK/PD model of homocysteine concentrations after high-dose methotrexate treatment in patients with acute lymphoblastic leukemia | Q31103489 | ||
| White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings. | Q31541956 | ||
| Necrotising leukoencephalopathy complicating treatment of childhood leukaemia | Q33619321 | ||
| Regulate axon branching by the cyclic GMP pathway via inhibition of glycogen synthase kinase 3 in dorsal root ganglion sensory neurons. | Q33843840 | ||
| Fine mapping of the chromosome 10q11-q21 linkage region in Alzheimer's disease cases and controls | Q33936532 | ||
| Case-Control Genome-Wide Association Study of Attention-Deficit/Hyperactivity Disorder | Q34085418 | ||
| The Trio family of guanine-nucleotide-exchange factors: regulators of axon guidance. | Q34330230 | ||
| Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia | Q34707586 | ||
| Shortening infusion time for high-dose methotrexate alters antileukemic effects: a randomized prospective clinical trial | Q35023522 | ||
| g:Profiler--a web server for functional interpretation of gene lists (2011 update). | Q35075627 | ||
| Biochemical and Clinical Aspects of Methotrexate Neurotoxicity | Q35114685 | ||
| Ancestry and pharmacogenetics of antileukemic drug toxicity | Q35828717 | ||
| Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia | Q36486782 | ||
| A quantitative MR imaging assessment of leukoencephalopathy in children treated for acute lymphoblastic leukemia without irradiation. | Q36677590 | ||
| Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments | Q37034349 | ||
| Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia | Q37065825 | ||
| Spectrin and ankyrin-based cytoskeletons at polarized domains in myelinated axons. | Q37119558 | ||
| Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects | Q37474395 | ||
| Netrin1 is required for neural and glial precursor migrations into the olfactory bulb | Q38335375 | ||
| Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. | Q39835436 | ||
| Aminophylline for methotrexate-induced neurotoxicity | Q42279602 | ||
| Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemia | Q42540530 | ||
| Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study | Q42542470 | ||
| Methotrexate-induced subacute neurotoxicity in a child with acute lymphoblastic leukemia carrying genetic polymorphisms related to folate homeostasis | Q42823939 | ||
| MRI in methotrexate-related leukoencephalopathy: Disseminated necrotising leukoencephalopathy in comparison with mild leukoencephalopathy | Q44450120 | ||
| Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia | Q44547442 | ||
| White matter and cerebral metabolite changes in children undergoing treatment for acute lymphoblastic leukemia: longitudinal study with MR imaging and 1H MR spectroscopy. | Q44630512 | ||
| Characterisation of the Wnt antagonists and their response to conditionally activated Wnt signalling in the developing mouse forebrain | Q45140257 | ||
| Gene expression in mouse brain following chronic hypoxia: role of sarcospan in glial cell death | Q46192392 | ||
| Folate homeostasis in cerebrospinal fluid during therapy for acute lymphoblastic leukemia | Q46207241 | ||
| Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer | Q46942425 | ||
| Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children | Q48337182 | ||
| Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD. | Q48954065 | ||
| Impact of acute lymphoblastic leukemia therapy on attention and working memory in children. | Q51030080 | ||
| Behavioral and educational limitations after chemotherapy for childhood acute lymphoblastic leukemia or Wilms tumor. | Q51945038 | ||
| Unexpected Acute Neurologic Toxicity in the Treatment of Children With Acute Lymphoblastic Leukemia | Q67738524 | ||
| Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome | Q81072434 | ||
| Methotrexate-associated alterations of the folate and methyl-transfer pathway in the CSF of ALL patients with and without symptoms of neurotoxicity | Q82592296 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| methotrexate | Q422232 | ||
| neurotoxicity | Q3338704 | ||
| toxic encephalopathy | Q7830379 | ||
| P304 | page(s) | 949-959 | |
| P577 | publication date | 2014-02-18 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia | |
| P478 | volume | 32 |
| Q91995942 | A Case of Methotrexate Neurotoxicity Presented as Status Epilepticus, Encephalopathy, and High Fever |
| Q48166171 | A PET/MR Imaging Approach for the Integrated Assessment of Chemotherapy-induced Brain, Heart, and Bone Injuries in Pediatric Cancer Survivors: A Pilot Study |
| Q89000382 | ALL relapse with multiple cranial nerve palsies and toxic leukoencephalopathy: treatment failure with treatment toxicity |
| Q88214817 | Association of Cerebrospinal Fluid Biomarkers of Central Nervous System Injury With Neurocognitive and Brain Imaging Outcomes in Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia |
| Q36925823 | Atypical Structural Connectome Organization and Cognitive Impairment in Young Survivors of Acute Lymphoblastic Leukemia |
| Q60044580 | Autoimmune Ataxia During Maintenance Therapy for Acute Lymphoblastic Leukemia |
| Q28829626 | BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy |
| Q53438232 | Behavioral symptoms and psychiatric disorders in child and adolescent long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. |
| Q40644146 | Behavioral, Social, and Emotional Symptom Comorbidities and Profiles in Adolescent Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. |
| Q36386943 | Bone marrow microenvironment modulation of acute lymphoblastic leukemia phenotype |
| Q88783078 | Brain Activity Associated With Attention Deficits Following Chemotherapy for Childhood Acute Lymphoblastic Leukemia |
| Q37653619 | Brain structure, working memory and response inhibition in childhood leukemia survivors. |
| Q33679931 | Central Nervous System Complications in Children Receiving Chemotherapy or Hematopoietic Stem Cell Transplantation |
| Q47327834 | Changes in cognition and dendritic complexity following intrathecal methotrexate and cytarabine treatment in a juvenile murine model |
| Q37659020 | Chemotherapy Pharmacodynamics and Neuroimaging and Neurocognitive Outcomes in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia |
| Q58608065 | Chemotherapy and the pediatric brain |
| Q38904676 | Chemotherapy-Related Neurotoxicity |
| Q28087637 | Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration |
| Q64935160 | Complications of Intrathecal Chemotherapy in Adults: Single-Institution Experience in 109 Consecutive Patients. |
| Q47792311 | Crisis management in the treatment of childhood acute lymphoblastic leukemia: putting right what can go wrong (emergency complications of disease and treatment). |
| Q90480744 | Curative effect of methotrexate combined with teniposide in the treatment of primary central nervous system lymphoma |
| Q57462209 | Disparities in Neurotoxicity Risk and Outcomes among Pediatric Acute Lymphoblastic Leukemia Patients |
| Q38986166 | Does genetic susceptibility increase risk for neurocognitive decline among patients with acute lymphoblastic leukemia? |
| Q37373153 | Drug interactions may be important risk factors for methotrexate neurotoxicity, particularly in pediatric leukemia patients. |
| Q55035485 | Effects of leucovorin (folinic acid) in the methotrexate-treated rat brain. |
| Q88931094 | Evaluation of standardized triple intrathecal therapy toxicity in oncohematological pediatric patients |
| Q53446289 | Evolution of neurocognitive function in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. |
| Q47136604 | FDG-Avid Intrathecal Inflammation Following Administration of Intrathecal Methotrexate |
| Q39165240 | Health-related quality of life of children on treatment for acute lymphoblastic leukemia: A systematic review. |
| Q64940961 | Hesperidin Alleviates Methotrexate-Induced Memory Deficits via Hippocampal Neurogenesis in Adult Rats. |
| Q97066996 | High-Dose Methotrexate-Induced Idiopathic Intracranial Hypertension in Infant Acute Lymphoblastic Leukemia |
| Q39427334 | How PET/MR Can Add Value For Children With Cancer |
| Q26738711 | In vitro models of medulloblastoma: Choosing the right tool for the job |
| Q39615014 | Influence of ADORA2A gene polymorphism on leukoencephalopathy risk in MTX-treated pediatric patients affected by hematological malignancies. |
| Q35945680 | Informative gene network for chemotherapy-induced peripheral neuropathy |
| Q35784497 | Inherited genetic variation in childhood acute lymphoblastic leukemia |
| Q90680308 | Intracranial Hemorrhage Following Oral Low-Dose Methotrexate After Multiple Toxicities Caused by High-Dose Methotrexate in Childhood Acute Lymphoblastic Leukemia |
| Q39361130 | Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis |
| Q47884623 | Long-term outcomes for children with acute lymphoblastic leukemia (ALL) treated on The Cancer Institute of New Jersey ALL trial (CINJALL). |
| Q41108418 | Malignant Cerebellar Edema Subsequent to Accidental Prescription Opioid Intoxication in Children |
| Q49585343 | Methotrexate-Induced Neurotoxicity: An Uncommon Stroke Mimic |
| Q91796308 | Methotrexate-Induced Subacute Neurotoxicity Surrounding an Ommaya Reservoir in a Patient with Lymphoma |
| Q42220380 | Methotrexate-induced leukoencephalopathy presenting as stroke in the emergency department. |
| Q36414199 | Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children's Oncology Group |
| Q38580062 | Neurocognitive Late Effects of Chemotherapy in Survivors of Acute Lymphoblastic Leukemia: Focus on Methotrexate |
| Q28084550 | Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: A systematic review |
| Q47561631 | Neurodevelopmental consequences of pediatric cancer and its treatment: applying an early adversity framework to understanding cognitive, behavioral, and emotional outcomes. |
| Q33557148 | Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy. |
| Q47843489 | Parental reports of behavioural outcome among paediatric leukaemia survivors in Malaysia: a single institution experience |
| Q35771188 | Polymorphisms in Genes Related to Oxidative Stress Are Associated With Inferior Cognitive Function After Therapy for Childhood Acute Lymphoblastic Leukemia |
| Q37496637 | Preventing and Managing Toxicities of High-Dose Methotrexate |
| Q38673114 | Rechallenging With Intrathecal Methotrexate After Developing Subacute Neurotoxicity in Children With Hematologic Malignancies |
| Q64060806 | Reduced brain microstructural asymmetry in patients with childhood leukemia treated with chemotherapy compared with healthy controls |
| Q41878956 | Stroke-like encephalopathy following high-dose intravenous methotrexate in an adolescent with osteosarcoma: a case report. |
| Q93188117 | Successful therapeutic rechallenge after a severe episode of high dose methotrexate-induced choreoathetosis: A case report |
| Q48331843 | Systematic review of pharmacogenomics and adverse drug reactions in paediatric oncology patients. |
| Q64973187 | The Impact of Persistent Leukoencephalopathy on Brain White Matter Microstructure in Long-Term Survivors of Acute Lymphoblastic Leukemia Treated with Chemotherapy Only. |
| Q40441874 | The PETALE study: Late adverse effects and biomarkers in childhood acute lymphoblastic leukemia survivors |
| Q39297348 | The Role of the Central Nervous System Microenvironment in Pediatric Acute Lymphoblastic Leukemia |
| Q88930662 | The Use of Ommaya Reservoirs to Deliver Central Nervous System-Directed Chemotherapy in Childhood Acute Lymphoblastic Leukaemia |
| Q57816122 | The effect of intravenous hydration strategy on plasma methotrexate clearance during intravenous high-dose methotrexate administration in pediatric oncology patients |
| Q48088797 | Transverse myelitis following methotrexate treatment of ectopic pregnancy: a case report |
| Q38848380 | Uric Acid and Neurocognitive Function in Survivors of Childhood Acute Lymphoblastic Leukemia Treated with Chemotherapy Only |
| Q49630698 | Utility and Safety of Intrathecal Methotrexate Treatment in Severe Anti-N-methyl-D-aspartate Receptor Encephalitis: A Pilot Study |
| Q53740078 | [Adverse effects of high-dose methotrexate therapy]. |
| Q95562019 | [Brain injury after induction chemotherapy in children with acute lymphoblastic leukemia] |
Search more.